Señales en vivo de OPK.TA | Maximiza tus Ganancias con Getagraph.com

Live Chart Being Loaded With Signals

Commentary (29 may 2024 @ 05:40):

OPKO Health, Inc., a healthcare company, engages in the diagnostics and pharmaceuticals businesses in the United States, Ireland, Chile, Spain, Israel, Mexico, and internationally...

Stats
Volumen de hoy	48 775.00
Volumen promedio	477 529
Capitalización de mercado	3.48B
EPS	ILA0 ( 2024-05-07 )
Próxima fecha de ganancias	( ILA0 ) 2024-07-31
Last Dividend	ILA0 ( N/A )
Next Dividend	ILA0 ( N/A )
P/E	-3.70
ATR14	ILA0.760 (0.15%)

Volumen Correlación

Largo: 0.09 (neutral)

Corto: 0.45 (neutral)

Signal:(35.811) Neutral

OPKO Health, Inc. Correlación

10 Correlaciones Más Positivas

10 Correlaciones Más Negativas

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

OPKO Health, Inc. Correlación - Moneda/Commodity

0.27
( neutral )

-0.60
( weak negative )

0.67
( moderate )

0.28
( neutral )

0.03
( neutral )

0.74
( moderate )

OPKO Health, Inc. Finanzas

Annual	2023
Ingresos:	ILA863.50M
Beneficio Bruto:	ILA318.13M (36.84 %)
EPS:	ILA-0.250

FY	2023
Ingresos:	ILA863.50M
Beneficio Bruto:	ILA318.13M (36.84 %)
EPS:	ILA-0.250

FY	2022
Ingresos:	ILA1.00B
Beneficio Bruto:	ILA288.20M (28.70 %)
EPS:	ILA-0.460

Financial Reports:

No articles found.

OPKO Health, Inc. Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

OPKO Health, Inc.

OPKO Health, Inc., a healthcare company, engages in the diagnostics and pharmaceuticals businesses in the United States, Ireland, Chile, Spain, Israel, Mexico, and internationally. The company's Diagnostics segment operates BioReference Laboratories that offers laboratory testing services for the detection, diagnosis, evaluation, monitoring, and treatment of diseases, including esoteric testing, molecular diagnostics, anatomical pathology, genetics, women's health, and correctional healthcare to physician offices, clinics, hospitals, employers and governmental units; and a novel diagnostic instrument system to provide blood test results in the point-of-care setting, as well as 4Kscore prostate cancer testing services. Its Pharmaceutical segment offers Rayaldee to treat secondary hyperparathyroidism in adults with stage 3 or 4 chronic kidney disease, and vitamin D insufficiency; OPK88004, an orally administered selective androgen receptor modulator; OPK88003, a once-weekly administered peptide for the treatment of type 2 diabetes and associated obesity that is in Phase IIb trials; and hGH-CTP, a once-weekly human growth hormone injection that completed Phase III clinical trial in partnership with Pfizer, Inc. This segment develops and commercializes longer-acting proprietary versions of already approved therapeutic proteins. The company also offers specialty APIs; develops, manufactures, markets, and sells pharmaceutical, nutraceutical, veterinary, and ophthalmic products; commercializes food supplements and over the counter products; manufactures and sells products primarily in the generics market; and imports, markets, distributes, and sells pharmaceutical products in a range of indications, including cardiovascular products, vaccines, antibiotics, gastro-intestinal products, hormones, and others. In addition, it operates pharmaceutical platforms in Ireland, Chile, Spain, and Mexico. The company was founded in 1991 and is headquartered in Miami, Florida.